Atlas Trials

HER2-zero, HER2-low and HER2-positive Tumors Distribution Across HR Expression Categories

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HER2-zero, HER2-low and HER2-positive Tumors Distribution Across HR Expression Categories

RecordFirmDate
Clinico-pathological and Genomic Features of HER2-low Early Breast Cancer (NCT07561346)Hellenic Cooperative Oncology Group1996-12-10

Track HER2-zero, HER2-low and HER2-positive Tumors Distribution Across HR Expression Categories automatically

Every clearance here is in the API, with alerts when new ones post.